Zoledronic Acid Injection
Product Images NDC 63323-961

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 63323-961). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Figure)

The text describes a figure (Figure 1) that shows the proportion of complete responders in pooled HCM studies by Day 10. The percentage of complete responders is displayed on the y-axis, ranging from 0% to 100%, and two medications are compared: Zoledronic acid Injection 4 mg and Pamidronate 90 mg. The figure indicates that the proportion of complete responders is higher for Zoledronic acid Injection compared to Pamidronate 90 mg. The statistical significance of the difference is also provided (P=0.002).*

FDA Label Image

Chemical Structure (Structure)

FDA Label Image

Vial (Vial)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.